Overview and Scope
Attention deficit hyperactivity disorder (ADHD) therapeutics refers to the range of treatments and interventions aimed at managing the symptoms and improving the functioning of individuals diagnosed with ADHD. ADHD is a neurodevelopmental disorder characterized by symptoms such as inattention, hyperactivity, and impulsivity that significantly interfere with daily functioning and development. The primary objective of ADHD therapeutics is to enhance attention, impulse control, and overall functioning in daily activities, thereby improving the quality of life for individuals affected by ADHD.
Sizing and Forecast
The attention deficit hyperactivity disorder (ADHD) therapeutics market size has grown strongly in recent years. It will grow from $12.37 billion in 2023 to $13.21 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to diagnostic awareness and screening programs, rising incidence of ADHD, advancements in treatment modalities, healthcare infrastructure development, and health insurance coverage expansion.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/attention-deficit-hyperactivity-disorder-adhd-therapeutics-global-market-report
The attention deficit hyperactivity disorder (ADHD) therapeutics market covered in this report is segmented –
1) By Drug Type: Stimulants, Non-Stimulants
2) By Psychotherapy: Behavior Therapy, Cognitive Behavioral Therapy, Interpersonal Psychotherapy, Family Therapy
3) By Age Group: Pediatric And Adolescent, Adult
4) By Distribution Channel: Hospital Pharmacies, Specialty Clinics, Retail Pharmacies, E-Commerce
North America was the largest region in the attention deficit hyperactivity disorder (ADHD) therapeutic market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the attention deficit hyperactivity disorder (ADHD) therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
https://www.thebusinessresearchcompany.com/sample.aspx?id=14042&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of attention-deficit hyperactivity disorder is expected to propel the growth of the attention-deficit hyperactivity disorder (ADHD) therapeutics market going forward. The rising prevalence of attention-deficit hyperactivity disorder (ADHD) refers to the growing number of individuals diagnosed with this neurodevelopmental disorder over time. ADHS therapeutics address the multifaceted nature of the condition, aiming to improve symptom management, functional impairment, quality of life, and overall well-being for individuals affected by ADHD. For instance, in January 2023, according to reports published by the Guardian, a US-based news publishing company, an estimated 170,000 identified patients were prescribed for ADHD in 2022, a 20.4% increase from the 141,000 identified patients during the same period in 2021. Therefore, the increasing prevalence of ADHD is driving the growth of the attention-deficit hyperactivity disorder (ADHD) therapeutic market.
Key Industry Players
Major companies operating in the attention deficit hyperactivity disorder (ADHD) therapeutics market are Pfizer Inc., Johnson And Johnson Services Inc., Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical’s, Eli Lilly and Company, Otsuka Pharmaceutical Co. Ltd., UCB S.A., Amneal Pharmaceuticals LLC, Lupin Ltd., Mallinckrodt Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Purdue Pharma L.P., Arbor Pharmaceuticals LLC, Tris Pharma Inc., NEOS Therapeutic Inc., Concert Pharmaceuticals Inc., Vayarin AG, Rhodes Pharmaceuticals L.P., KemPharm Inc., Impax Laboratories Inc., Aevi Genomic Medicine, Adlon Therapeutics L.P., Ironshore Pharmaceuticals Inc., Highland Therapeutics Inc.
The attention deficit hyperactivity disorder (adhd) therapeutics market report table of contents includes:
- Executive Summary
- Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Characteristics
- Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Trends And Strategies
- Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market – Macro Economic Scenario
- Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size and Growth
…………….
- Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Competitive Benchmarking
- Global Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Competitive Dashboard
- Key Mergers And Acquisitions In The Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market
- Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Future Outlook and Potential Analysis
- Appendix
Related Reports:
https://goodprnews.com/paper-and-paperboard-packaging-trends/
https://goodprnews.com/portable-dialysis-machines-market-trends/
https://goodprnews.com/semiconductor-etch-equipment-market-analysis/
https://goodprnews.com/therapeutic-hair-oil-market-players/
https://topprnews.com/paper-and-paperboard-packaging-market-forecast/
https://topprnews.com/portable-dialysis-machines-market-insights/
https://topprnews.com/semiconductor-etch-equipment-market-share/
https://topprnews.com/therapeutic-hair-oil-market-share/
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
